Kera Capital Partners, Inc. Eledon Pharmaceuticals, Inc. Transaction History
Kera Capital Partners, Inc.
- $347 Billion
- Q4 2024
A detailed history of Kera Capital Partners, Inc. transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Kera Capital Partners, Inc. holds 25,770 shares of ELDN stock, worth $104,883. This represents 0.03% of its overall portfolio holdings.
Number of Shares
25,770Holding current value
$104,883% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ELDN
# of Institutions
37Shares Held
18.7MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA6.29MShares$25.6 Million0.5% of portfolio
-
Armistice Capital, LLC New York, NY2.36MShares$9.62 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.57MShares$6.37 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.5MShares$6.11 Million0.03% of portfolio
-
Zimmer Partners, LP New York, NY1.43MShares$5.84 Million0.07% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $56M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...